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We have used a competitive nymtilinkcd immunoassay with a panel of monoclonal antibodies to probe the topography of the membrane-bound 
form of apolipoprotein B (apo 5) in rabbit microsomes. All epitopcsinvestigated were found to be expressed at the cytosolic side of the microsomal 
membrane under conditions in which the vesicles remained sealed. Thcsc results indicate that the membrane-associated form of apolipoprotein 
B is either at thccytosolic sideofthcendoplasmic reticulum membrane or integrated into the membrane. From this site apo B may bc trandocatcd 
to the lumen for assembly into VLDL or may be degraded. 
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1, INTRODUCTION 2.3. St~bceffrrtur fk crims 
Total microsomes (endoplasmic reticulum) were prepared as de- 
scribed previously for rat liver [I41 with the addition of a cocktail of 
protcase inhibitors to the homogenate [6]. In some experiments the 
secretory proteins in the lumen were labelled by injection of [‘Hlleu- 
tine (I00 ,Ki) into the portal vein 15-30 min before removal of the 
liver [ 151, 
Apolipoprotein B (apo B) is essential for the secretion 
of very low density lipoproteins (VLDL) from liver and 
plays an important role in determining the plasma 
cholesterol evels. Translocation of apo I3 across the 
endoplasmic reticulum membrane and itsassembly with 
lipid is of special interest as this protein is very large 
(512 kDa) and hydrophobic. Moreover, apo B does not 
behave as a typical secreted protein but exists in mem- 
brane-bound and cisternal forms in both the endoplas- 
mic reticulum and the Golgi region {l-8]. Studies of 
HEP-G2 cells have suggested that the membrane-bound 
form of apo B is a precursor of the secreted form [9-l 11. 
In this investigation we have used a panel of monoclo- 
nal antibodies against rabbit apo B to probe the topog 
raphy of membrane-bound apo B in rabbit microsomal 
membranes. 
2. MATERIALS AND METHODS 
2. I ti Anitncds 
Dwarf lopcar or small New Zealand white rabbits (approximately 
2 kg) were used for all studies. 
2.2. Autiihdies 
Monoclonal antibodies pecific for rabbit ape-6 (MAC 22,27, 2B, 
29 and 31) and sheep anti-rabbit apo B antiserum were prepared as 
described previously [19. 
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2.4. ELISA 
LDL prepared from rabbit serum (d I ,019-d 1.063 fraction-OS3jrg 
apo B per well) were placed in EIJSA pIales (Nunc) which were sealed 
wi:h clingfilm and refrigerated overnight. The wells were washed rour 
times with TBS (50 mM Tris, 200 mM N&I. pH 7.4) containing 0.05% 
(v/v) Twecn 20 and O,S% (w/v) RIA grade bovine serum albumin 
(BSAI and blocked for 2 h with TBS containing 3% BSA. The wells 
were aspirated and 100 ~1 of antibody (dilutions up to 1:2OO,OUO) in 
TBS containing 1% BSA were added together with 50~1 of buffer or 
50 pl of LDL (0.1-200 pg apo B/ml) or 50 @I of microsmnes and 
incubated overnight with shaking. The wells were washed four times 
as above and l5O#l of secondary antibody (goat anti-rat IgG coupled 
to alkaline phosphatase (Sigma) for monoclonals or donkey unti-sheep 
coupled to alkaline phosphatase for polyclonals (Sigma)) diluted 
1: 1000 in TBS containing I% BSA were added. Platcs rvm incubated 
for 4 h and washed four times as above followed by a wash with 0, I 
M glycine burer. pH 10,4, COnhhing 0.001 M MgCll and ZnCl. 
Alkaline phosphatasc bound was measured usingp-nitrophenyl-phos- 
phate (Sigma); terminated by addition of 5Oyl of 0.1 M EDTA after 
30 min. and read at 405 nm in an LKB plate-reader. In some experi- 
ments 0.4% taurocholate was added lo open the microsomul vesicles 
II 61. 
Integrity was dctermincd by (i) measurement of the leatcagc of 
radiolabelled secretory proteins during ELISA assays, and (ii) by 
determination of the availability of albumin, a lumen protein, to anti- 
albumin antibody in the incubation medium. For(i), afterincubation. 
the microsomes from triplicate wells were removed, diluted lo 10 ml 
with 0.25 M suctosc and centrifuged at 105.000 x g for 45 min. 
Aliquots of the supcrnatants and the resuspended microsomes were 
precipitated by addition ofan equal volumeof 15% trichloracetic acid. 
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The denatured protein was isolated by centrifugation, solubilised in 
Beckman tissue solubiliser and counted. For (ii), competiGon curves 
with and without taurocholate were prepared for albumin as above 
except hat crystalline human albumin (fraction V, Sigma) replaced 
LDL: gelatin replaced BSA in I!K blocking and wash solutions; and 
the secondary antibody was goat anti-human albumin (Sigma). In 
preliminary experiments it wasdemonstraled by immunoblotting that 
theanti-human albumin antibody cross-reacts with rabbit serum albu- 
min. 
3. RESULTS AND DISCUSSION 
The ability of LDL-apo B to compete with a fixed 
amount of immobilised LDL-apo I3 varied for each 
monoclonal antibody. SO% inhibition of antibody bind- 
ing to the immobilised LDL occurred at 1.98 ,~g apo 
B/well for MAC 22, 0.63 ,~g apo B/well for MAC 27, 
0.035 pg apo B/well for MAC 28,0.99 ,~ug apo B/well for 
MAC 29, and 0.25 fig apo B/well for MAC 31 compared 
with 0.63 ,ug apo B/well for sheep anti-rabbit apo B 
antiserum. When the assays were performed in the pres- 
ence of taurocholate the competition curve obtained for 
each antibody was unchanged. 
The expression of epitopes of apo B at the surface of 
microsomal vesicles was assessed by determining their 
abi!ity to compete with immobilised LDL-apo P for the 
range of monoclonal antibodies (Table I). The apo B 
content of the microsomes was calculated from RIA 
[7,8] and ELISA using sheep anti-rabbit apo B antise- 
rum and the distribution of apo I3 between the mem- 
brane and cisternal contents determined by RIA [7,8]. 
Table I 
Expression of epitopes ofapo B in microsomal vesicles compared with 
LDL-apo B 
Monoclonal % Inhibition 8 Expected 
anlibody inhibition” 
Uf~opened tnicrosoms 
MAC 22 47.03 c_ 5,39 (9) 43.2 P > 0.05 
MAC 27 G4,43 -t 3.45 (f3) 78.4 P < 0,002 
MAC 28 57.53 + 2,38 (3) 92.3 P < 0.002 
MAC 29 S2,80 f 602 (9) 73.4 P c 0.002 
MAC 31 56.37 t- 2% (3) 81.3 P c 0.002 
Opelled vesicles” 
MAC 22 82.67 2 3.6 (3) 80. I P > 0.1 
MAC 27 90.43 + 6.43 (3) 94,3 P > 0,I 
MAC 38 82.25 + 5.26 (5) 96.3 P c 0.01 
MAC 29 81.55 + 0.62 (3) 88.6 P > 0.05 
MAC 31 94.00 1O.G” (3) 96.6 P > 0.1 
Results are expressed as mean 2 SD (number of observations). 
“The expected inhibition was determined from the standard curve for 
LDL performed simultaneously. The 8 expected inhibition for uno- 
pened vesicles is calculated from the apo B of the membrane fraction 
and that for opened vesicles from the total apo B of the microsomal 
fraction. 
b Microsomes wcrc opened by addition of 0.4% taurocholate [I61 to 
tk incubation. The LDL competition curve was performed simulta- 
neously in lhc presence of the same detergent. 
From these values we c&ulated the % inhibition which 
would bc expected if all of the membrane-bound pool 
of apo B is exposed at the vesicle surface in a similar 
way to that in LDL, This was compared with the actual 
% inhibition by the s&cellular fracations. Closed mi- 
crosomal vesicles competed with immobilised LDL for 
all monoclonal antibodies. However, only the epitope 
recognized by MAC 22 competed on an equal basis with 
LDL apo B, while those for MAC 27,28,29 and 31 were 
less effective competitors indicating that these epitopes 
in membrane-bound apo B are partly shielded com- 
pared with LDL apo B. When the microsomal vesicles 
were opened with taurocholate to expose both the cis- 
ternal surface of the membrane and apo B in the cister- 
nal contents the % inhibition of antibody binding was 
similar to that which would be expected if the total apo 
B of the microsomes behaved as LDLapo B (Table I). 
Two control experiments indicated that microsomal 
vesicles remained sealed during the ELISA (Table II). 
It was demonstrated that there was no loss of radiola- 
belled protein over the incubated control into the me- 
dium during ELLSA. Furthermore albumin, a secretory 
protein in the microsomal vesicles, could not be detected 
by ELISA using an anti-albumin antibody unless the 
vesicles were opened with taurocholate. 
The epitope for MAC 31 is in the N-terminal 48% 
(recognises apo B48); that for MAC 22 is in the N- 
terminal 48-74% (recognises apn B74) and those for 
MAC 27,28 and 29 are located in the C-terminal 26% 
Table II 
Investigation of the integrity of microsomal vesicles during ELISA 
Treatment before centrifuption 96 loss of labelled 
protein into supernatant 
Untreated microsomes held on ice 
in 0.25 M sucrose 11.10 C 3.86 
Microsomes incubated on ELISA 
plates with TBS-BSA 13.70 z? 2.88 
Microsomcs incubated on ELISA 
plales in complete ssay medium 14.44 2 4.36 
Microsomes incubated on ELISA 
plates in complete assay medium 
plus 0.4% taurocholate 76.80 ?: 1.56 
Values given are the average of four separate assays 2 SD. 
(6) A vai(abi!it.v o/ afhurnirt in a~icrmmes for probing by unri-albumin 
% Inhibition Albumin detected 
(ng/mg cnicrosomal 
protein) 
No compelin& albumin 0% 0 
Microsomcs 0% 0 
Microsomcs + 
0.4% taurocholale SO--GO% 15.49 + 3.55 
Values are the average of 8 experiments performed in duplicate. 
2s 
Volume 304. nunber 1 FEBSLETTERS June 1992 
(recognises apo BlOO) [13]. Our observations therefore 
suggest hat multiple regions throughout the length of 
the apo B molecule are exposed at the cytosolic surface 
of the microsomal membrane. We have not directly 
addressed the question whether apo B has transmem- 
brane domains although our results are consistent with 
this possibility. Apo 13 lacks hydrophobic regions of 
sufficient length to provide conventional transmem- 
brane a-helical domains. However, recent studies of 
bacterial porins have demonstrated that shorter hydro- 
phobic &sheets, which are found in apo B, may form 
t;,ansbilayer domains in membrane proteins [171. 
Kinetic studies in HEP-G2 cells have indicated that 
the membrane-bound apo B is a precursor of the cister- 
nal apo B, which is packaged with lipid for secretion 
[9,10] and that apo B which is not assembled with lipid 
is degraded [II]. The possibility that apo I3 is inserted 
into the endoplasmic reticulum is of interest in view of 
the recent observations that charged amino acids in 
transmembrane r gions may be the structural motif nec- 
essary for targetting membrane-bound proteins for deg- 
radation [18]. Similar mechanisms may be involved in 
the degradation of membrane-bound apo B in liver 
cells. 
nrkr~o1~‘~~~119~‘/~tr~?l,~: This rcsearch was supported by grants from the 
British Heart Foundation and by the award of a SERC-CASE 
Studentship (to J,W.j sponsored by Smith Kline Beechtim. 
REFERENCES 
[I] Davis, R.A., Thrift, R.N., Wu, CC arid Howell, K.E. (1990) J. 
Biol. Cbcm. 265, 10005-1001 I. 
[t 01 
1111 
II4 
1131 
[I4 
u 51 
(161 
Bambcrgcr. M.J. and Lane, M,D. (1986) J. Biol. Chcm, 263, 
11868-I 1876. 
Borchardt, R.A. and Davis. R,A. (1987) J, Biol, Chem, 2G2, 
36394-16402, 
Wang, L. and Pino (1987) Eur. J. Biochcm. 164, 357-367. 
Cartwright, I.J. and Higgins. J.A. (1990) Bjochcm. Sec. Trans. 
18, 1176-1177. 
Cartwright. I.J. and Higgins. J.A. (1992) Biochem. J. (in press). 
Wilkinson, J., Higgins, J.A.. Groot, P.W.E., Gherardi, E. and 
Bawyer, D.E. (1990) Biochem, Sot. Trans. 18, 1181. 
Wilkinson, J., Higgins, J.A.. Groat, P.H.E., Gherardi, E. and 
Bowyer, D.E. (1992) (submitted). 
Bostrom, E,, Borep, J., Wettesten, M., Sjoberg, A,, Bondjers. G., 
Wiklund. 0,, Carlsson. P. und Olofsson. S-0. (1988) J. Biol, 
Chcm. 263.4434-4442. 
Boren, J., Wettesten, M., Sjoberg, A., Thorlin, T,, Bondjcrs, G., 
Wiklund, 0, and Olofsson, S.-O. (1990) J, Biol. Chem. 26S, 
10556-10564. 
Dixon. J.L., Furukawa, S. and Ginsberg, H.K. (1991) J. Biol. 
Chem. 266, 5080-5086. 
Sato, R., fmanaka, T., Takasluki, A. and Takano, T. (1990) J. 
Biol. Chem. 265, 11880-11884, 
Gherardi, E,, Hutchings, A., Cialfre, G. and Bowyer, DE. (1988) 
Biochem. J. 2S2, 237-245. 
Higgins, J.A. and Fieldsend, J.K. (1987) J. Lipid Res. 28, 268- 
278. 
Kreibich, G,, Debcy, P. and Sabatinni, D.D. (1973) J. Cell Biol, 
58, 436-462. 
Arion, W.J., Ballas, L.M., Lange, A.J. and Wallin, B.K. (1976) 
J. Rio]. Chem. 251, 4901-4907. 
[17] Weiss, MS., Weckesscr. A-J., Welte, W., Schilz, E, and Schulz, 
G.E. (1991) Science 254, 1627-lG30. 
[ 181 Bonifacio, J.S. and Lippincott-Schwartz, 3.(1991) Current Opin- 
ion in Cell Biology 3, 592-600. 
26 
